Add office photos
Engaged Employer
SAI Life Sciences
4.0
based on 1.2k Reviews
Video summary
Company Overview
Company Locations
Working at SAI Life Sciences
Company Summary
SAI Life Sciences collaborates with pharmaceutical and biotech firms to expedite the development and manufacturing of complex molecules in the healthcare industry.
Overall Rating
4.0/5
based on 1.2k reviews
3% above
industry average
Highly rated for
Salary, Skill development, Company culture
Critically rated for
Promotions
Work Policy
Work from office
79% employees reported
Monday to Friday
42% employees reported
Flexible timing
53% employees reported
No travel
49% employees reported
View detailed work policy
Top Employees Benefits
Office cab/shuttle
95 employees reported
Job/Soft skill training
72 employees reported
Cafeteria
58 employees reported
Health insurance
40 employees reported
View all benefits
About SAI Life Sciences
Founded in1999 (26 yrs old)
India Employee Count1k-5k
Global Employee Count1k-5k
India HeadquartersHyderabad, India
Office Locations
Websitesailife.com
Primary Industry
Other Industries
View in video summary
Sai Life Sciences is built on the bedrock of partnership. We work with innovator pharma and biotech companies to accelerate the discovery, development and manufacture of complex small molecules for a healthier tomorrow. Our Vision is to support our global innovator partners bring 25 new medicines to life by 2025. And we are well on that journey.
Mission: Sai provides services to our pharma innovator partners, which accelerate discovery, development and manufacture of complex small molecules. Sai commits to being reliable, fully compliant and continuously get better at every aspect of our service.
Vision: Sai Life Sciences will facilitate launch of 25 new medicines by our global innovator partners through 2025 and achieve $250 million in annual revenue. For our employees, we will cultivate a stimulating work environment and become one of the top 3 CDMO’s to work for by 2020. Our actions are guided by a culture of integrity and respect while embracing our social responsibility.
Report error
SAI Life Sciences Ratings
based on 1.2k reviews
Overall Rating
4.0/5
How AmbitionBox ratings work?
5
482
4
412
3
153
2
74
1
95
Category Ratings
3.9
Salary
3.9
Skill development
3.8
Company culture
3.7
Work-life balance
3.6
Job security
3.6
Work satisfaction
3.3
Promotions
SAI Life Sciences is rated 4.0 out of 5 stars on AmbitionBox, based on 1.2k company reviews. This rating reflects a generally positive employee experience, indicating satisfaction with the company’s work culture, benefits, and career growth opportunities. AmbitionBox gathers authentic employee reviews and ratings, making it a trusted platform for job seekers and employees in India.
Read more
Gender Based Ratings at SAI Life Sciences
based on 1.2k reviews
3.9
Rated by 128 Women
Rated 3.8 for Job security and 3.7 for Company culture
4.0
Rated by 1.1k Men
Rated 4.0 for Salary and 3.9 for Skill development
Work Policy at SAI Life Sciences
based on 192 reviews in last 6 months
Work from office
79%
Hybrid
18%
Permanent work from home
3%
SAI Life Sciences Reviews
Top mentions in SAI Life Sciences Reviews
+ 5 more
Compare SAI Life Sciences with Similar Companies
 |  Change Company |  Change Company |  Change Company | |
|---|---|---|---|---|
Overall Rating | 4.0/5 based on 1.2k reviews | 3.9/5 based on 2.1k reviews | 3.9/5 based on 1.7k reviews | 3.8/5 based on 4.5k reviews |
Highly Rated for | Skill development Salary Company culture | Job security Skill development Work-life balance | Work-life balance | Job security Work-life balance Company culture |
Critically Rated for | Promotions | Promotions | Promotions | Promotions |
Primary Work Policy | Work from office 79% employees reported | Work from office 82% employees reported | Work from office 74% employees reported | Hybrid 72% employees reported |
Rating by Women Employees | 3.9 Good rated by 128 women | 3.7 Good rated by 387 women | 3.8 Good rated by 185 women | 3.9 Good rated by 1.8k women |
Rating by Men Employees | 4.0 Good rated by 1.1k men | 3.9 Good rated by 1.6k men | 3.9 Good rated by 1.4k men | 3.8 Good rated by 2.5k men |
Job security | 3.6 Good | 4.0 Good | 3.7 Good | 3.9 Good |
View more
SAI Life Sciences Salaries
SAI Life Sciences salaries have received with an average score of 3.9 out of 5 by 1.2k employees.
Research Chemist
(331 salaries)
Unlock
₹2.3 L/yr - ₹6.7 L/yr
Executive Production
(225 salaries)
Unlock
₹2.4 L/yr - ₹5.2 L/yr
Research Associate
(209 salaries)
Unlock
₹2.9 L/yr - ₹10.1 L/yr
Senior Research Associate
(175 salaries)
Unlock
₹4.9 L/yr - ₹13.4 L/yr
Senior Research Chemist
(163 salaries)
Unlock
₹3.6 L/yr - ₹8.8 L/yr
Associate Research Scientist
(149 salaries)
Unlock
₹6.1 L/yr - ₹15 L/yr
Deputy Manager
(108 salaries)
Unlock
₹7.7 L/yr - ₹16.1 L/yr
Research Scientist
(104 salaries)
Unlock
₹5.2 L/yr - ₹16.6 L/yr
Research Assistant
(68 salaries)
Unlock
₹2.6 L/yr - ₹6.5 L/yr
Senior Research Scientist
(48 salaries)
Unlock
₹10 L/yr - ₹20.3 L/yr
SAI Life Sciences Interview Questions
A Hvac Engineer was asked Q. What is the efficiency of H13 and H14 filters?
A Research Chemist was asked 8mo agoQ. Can you describe NMR and how to interpret the data?
A Senior Research Chemist was asked 11mo agoQ. How do you convert an aldehyde to a Wittig reagent?
An Executive was asked 2mo agoQ. What strategies do you employ to enhance preventive maintenance?
A Research Associate was asked Q. N-alkylation of primary and secondary amines
SAI Life Sciences Jobs
Popular Skills SAI Life Sciences Hires for
Current Openings
SAI Life Sciences News
View all
NDTV Profit Pulse On June 16 — Top 8 Stories At 8 P.M. Under 8 Minutes
- India's trade deficit narrowed more than expected in May as imports fell, offering relief to macro watchers. Wholesale inflation cooled to a 14-month low with food prices easing notably.
- Passenger vehicle sales slipped slightly in May, while Vishal Mega Mart and Sai Life Sciences shares are set to exit lock-in periods.
- Despite Middle East tensions, markets ended higher, and SBI cut savings deposit rates to a record low of 2.5%.
- Key headlines include the trade deficit narrowing to $21.88 billion in May, wholesale inflation easing to 0.39% in May, and the recovery of the Cockpit Voice Recorder from the Air India crash.
- Additionally, passenger vehicle sales dipped 0.8% in May, SBI slashed its savings account rate to 2.5%, and shares worth Rs 39,000 crore are set to exit lock-in periods.
- US President Donald Trump mentioned Israel and Iran may need to 'fight it out' before reaching a peace deal, while markets closed higher with Brent crude ending lower after early spikes.
Bloomberg Quint | 16 Jun, 2025
Vishal Mega Mart, Sai Life Sciences: Shares Worth Rs 39,000 Crore To Exit Lock-Ins On Tuesday
- Shares worth over Rs 39,385 crore of Vishal Mega Mart Ltd. and Sai Life Sciences Ltd. are set to exit lock-ins on Tuesday as per Nuvama's report.
- As much as 56% equity of Vishal Mega Mart and 48% equity of Sai Life Sciences is becoming eligible for trade.
- 254.2 crore shares of Vishal Mega Mart worth Rs 31,775 crore will be free to trade, almost four times more than the IPO size.
- Vishal Mega Mart debuted strongly, listing at Rs 104 against the IPO price of Rs 78, now trading around Rs 125 with a 60% return.
- Sai Life Sciences had a robust post-IPO performance, listing at Rs 764 against the IPO price of Rs 549, currently trading at Rs 763.
- Analysts' view on Vishal Mega Mart - seven recommend 'Buy', one 'Hold', one 'Sell', with targets ranging from Rs 90 to Rs 161.
- Sai Life Sciences is tracked by four analysts, two 'Buy', one 'Hold', one 'Sell', with the most bullish target at Rs 911 by Morgan Stanley.
- Shares worth Rs 31,775 crore of Vishal Mega Mart and Rs 7,610 crore of Sai Life Sciences will become free to trade.
- Vishal Mega Mart and Sai Life Sciences have impressive investor confidence and performance post-IPO.
- Vishal Mega Mart's equity value post lock-in period is nearly four times the IPO size, while Sai Life Sciences' value is 2.5 times the IPO size.
- Vishal Mega Mart stock surged from IPO price of Rs 78 to current Rs 125, representing a 60% return.
- Sai Life Sciences' stock listed at Rs 764, currently trading at Rs 763, showing investor confidence.
- Analysts foresee positive outlook for both Vishal Mega Mart and Sai Life Sciences stocks with varied target prices.
- The news mentions the end of the lock-in period for the shares of Vishal Mega Mart and Sai Life Sciences on Tuesday.
- Investor interest remains strong in both companies, with Vishal Mega Mart showing a 60% return over the IPO price and Sai Life Sciences remaining 38% above its issue price.
Bloomberg Quint | 16 Jun, 2025
Heard On The Street: Dealers Spot Action In Bajaj Finance, ICICI Prudential Life, ICICI Lombard, and Sai Life
- Dealers spot potential bonus issue announcement in Bajaj Finance.
- Sell flows expected for ICICI Prudential Life Insurance and ICICI Lombard ahead of weak Q4 results.
- Block deal anticipated in Sai Life Sciences and Medanta, with a large private equity investor potentially offloading stake.
- Strong buying interest observed in Ramky Infrastructure due to a potential significant order win.
Bloomberg Quint | 11 Apr, 2025
Sai Life Sciences sets up Peptide Research Center in Hyderabad
- Sai Life Sciences has established a dedicated Peptide Research Center at its R&D Campus in Hyderabad.
- The center aims to meet the growing demand for complex peptide synthesis and conjugation.
- It offers specialized services across peptide synthesis, discovery, and advanced modalities.
- The facility integrates automation, high-throughput systems, and advanced liquid handling for efficient development of peptide-based therapeutics.
HinduBusinessLine | 3 Apr, 2025
Stock Recommendations Today: Tata Motors, Waaree Energies, Patanjali On Brokerages' Radar
- Tata Motors, Waaree Energies, and Patanjali Foods are in focus for brokerages, with various ratings and target prices discussed.
- HSBC upgraded Tata Motors to 'buy' from 'hold' with a reduced target price, citing growth triggers in margin expansion and recovery in business sectors.
- Jefferies initiated a 'hold' rating for Waaree Energies, highlighting the benefits from policy tailwinds but cautioning about potential oversupply challenges by 2028.
- Patanjali received a 'buy' rating from Jefferies, emphasizing its diversified consumer franchise, acquisition strategies, and expected growth in revenue and margins.
- Sai Life Sciences garnered a 'hold' rating from Jefferies, noting its track record and growth potential but stating limited upside due to high current valuation.
- JSW Energy maintained a 'buy' rating with an increased target price, projecting improved financial performance and growth in Ebitda in the coming years.
- BofA kept a 'buy' rating for Bajaj Auto, foreseeing growth opportunities in new segments, domestic volumes, and exports in the near future.
- Citi upgraded Gujarat State Petronet to 'buy', citing positive developments with a new pipeline project and potential tariff benefits in the long term.
- Overall, brokerages provide insights on these companies, highlighting growth prospects, challenges, and investment recommendations for investors to consider.
- Stay updated on stock recommendations and market trends with NDTV Profit's analyst calls and expert opinions.
Bloomberg Quint | 17 Mar, 2025
Mobikwik To Vishal Mega Mart: Shares Worth Rs 3,500 Crore To Exit Lock-Ins Next Week
- Shares worth over Rs 3,500 crore, including those of One Mobikwik Systems Ltd. and Vishal Mega Mart Ltd., are set to exit their respective lock-in periods next week.
- 6% of equity for One Mobikwik Systems is set to become eligible for trade as they exit the second lock-in expiry period for anchor investors.
- Vishal Mega Mart will see the largest value of shares becoming free to trade on March 17 at Rs 1,527 crore.
- Shares of Sai Life Sciences Ltd. and Inventurus Knowledge Solutions Ltd. are also set to exit their lock-in periods.
Bloomberg Quint | 13 Mar, 2025
Stock Market Today: All You Need To Know Going Into Trade On Feb. 21
- The NSE Nifty 50 and BSE Sensex closed lower on Thursday, with underperformance in financial heavyweights like HDFC Bank Ltd. and ICICI Bank Ltd.
- Foreign portfolio investors were net sellers while domestic institutional investors continued buying streak for the 12th session.
- The Indian rupee strengthened against the US dollar, closing at Rs 86.66 per dollar.
- Earnings post market hours showed mixed results with CIE Automotive and Sanofi Consumer reporting changes in revenue, Ebitda, and net profit.
- Stocks to watch include JM Financial, NTPC Green Energy, Vedanta, Religare Enterprises, Cipla, and more as they make significant announcements.
- Bulk deals and insider trading activities were highlighted for companies like Isgec Heavy Engineering, Sai Life Sciences, and others.
- Listing day for Quality Power Electrical Equipments is set for Friday after a successful IPO subscription rate.
- Trading tweaks included companies moving in and out of the Short-Term ASM Framework, F&O cues, and research reports from ICICI Securities, Anand Rathi, DRChoksey, and more.
- Overall, the stock market today reflected a mix of company performances, investor activities, and future outlooks.
- For more updates, viewers can watch live TV, get stock market updates, top business, IPO news on NDTV Profit.
Bloomberg Quint | 21 Feb, 2025
Powered by
SAI Life Sciences Offices
Compare SAI Life Sciences with
Aragen Life Sciences
4.0
Parexel International
3.9
ICON Plc
4.1
Fortrea Development India Private Limited
3.9
Syneos Health
3.8
Reliance Life Sciences
3.6
Lambda Therapeutic Research
4.2
Aizant Drug Research Solutions
3.8
Veeda Clinical Research
3.8
Equinox Labs
3.9
Cliantha Research
3.9
MRO
3.0
Navitas Life Sciences
3.4
Perceptive
3.5
ClinChoice
4.0
National Environmental Engineering Research Institute
4.5
National Chemical Laboratory
4.2
Waters Corporation
4.0
Clario
4.0
O2H Group
3.9
Contribute & help others!
You can choose to be anonymous
Companies Similar to SAI Life Sciences
IQVIA
Consulting, Healthcare / Pharma, Internet, Analytics & KPO, Clinical Research, Healthcare, Pharma
3.8
• 4.5k reviews
Syngene International
Clinical Research
3.9
• 2.1k reviews
SGS
Advertising / PR / Events, Agriculture, Chemicals / Agri Inputs, Recruitment, Engineering & Construction, Clinical Research, Printing & Publishing
3.9
• 1.7k reviews
Aragen Life Sciences
Biotech & Life sciences, Analytics & KPO, Clinical Research
4.0
• 1.6k reviews
Parexel International
Healthcare / Pharma, Manufacturing, Analytics & KPO, Clinical Research, Pharma
3.9
• 1k reviews
ICON Plc
Biotech & Life sciences, Clinical Research, Pharma
4.1
• 858 reviews
Fortrea Development India Private Limited
Biotech & Life sciences, Analytics & KPO, Clinical Research
3.9
• 817 reviews
Syneos Health
Biotech & Life sciences, Analytics & KPO, Clinical Research
3.8
• 676 reviews
Reliance Life Sciences
Financial Services, Clinical Research
3.6
• 468 reviews
Lambda Therapeutic Research
Clinical Research, Pharma
4.2
• 392 reviews
Aizant Drug Research Solutions
Analytics & KPO, Clinical Research
3.8
• 358 reviews
Veeda Clinical Research
Clinical Research, Pharma
3.8
• 320 reviews
SAI Life Sciences FAQs
When was SAI Life Sciences founded?
SAI Life Sciences was founded in 1999. The company has been operating for 26 years primarily in the Clinical Research sector.
Where is the SAI Life Sciences headquarters located?
SAI Life Sciences is headquartered in Hyderabad. It operates in 3 cities such as Bidar, Bangalore / Bengaluru, Hyder. To explore all the office locations, visit SAI Life Sciences locations.
How many employees does SAI Life Sciences have in India?
SAI Life Sciences currently has more than 2,700+ employees in India. Research & Development department appears to have the highest employee count in SAI Life Sciences based on the number of reviews submitted on AmbitionBox.
Does SAI Life Sciences have good work-life balance?
SAI Life Sciences has a Work-Life Balance Rating of 3.7 out of 5 based on 1,200+ employee reviews on AmbitionBox. 74% employees rated SAI Life Sciences 4 or above, while 26% employees rated it 3 or below on work-life balance. This indicates that the majority of employees feel a generally balanced work-life experience, with some opportunities for improvement based on the feedback. We encourage you to read SAI Life Sciences work-life balance reviews for more details.
Is SAI Life Sciences good for career growth?
Career growth at SAI Life Sciences is rated as moderate, with a promotions and appraisal rating of 3.3. 26% employees rated SAI Life Sciences 3 or below, while 74% employees rated it 4 or above on promotions / appraisal. This rating suggests that while some employees view growth opportunities favorably, there is scope for improvement based on employee feedback. We recommend reading SAI Life Sciences promotions / appraisals reviews for more detailed insights.
What are the pros and cons of working in SAI Life Sciences?
Working at SAI Life Sciences comes with several advantages and disadvantages. It is highly rated for salary & benefits, skill development and company culture. However, it is poorly rated for promotions / appraisal, work satisfaction and job security, based on 1,200+ employee reviews on AmbitionBox.
Stay ahead in your career. Get AmbitionBox app
Trusted by over 1.5 Crore job seekers to find their right fit company
80 Lakh+
Reviews
10L+
Interviews
4 Crore+
Salaries
1.5 Cr+
Users
Contribute to help millions
AmbitionBox Awards
Get AmbitionBox app
Made with ❤️ in India. Trademarks belong to their respective owners. All rights reserved © 2025 Info Edge (India) Ltd.
Follow Us
